Ampio Pharmaceuticals Navigation
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Overview
    • About Ampion
    • Inflammatory Joint Disease
    • Inflammatory Lung Diseases, COVID-19
    • Inflammatory Kidney Diseases
    • Rare Inflammatory Pediatric Diseases
  • Manufacturing
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Overview
    • About Ampion
    • Inflammatory Joint Disease
    • Inflammatory Lung Diseases, COVID-19
    • Inflammatory Kidney Diseases
    • Rare Inflammatory Pediatric Diseases
  • Manufacturing
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
Home News Ampion featured in Denver Business Journal

Ampion featured in Denver Business Journal

Download the PDF article.

Real Time Quote

SUBSCRIBE

Get email notifications of the latest Ampio news.
Loading

Latest News

Ampio Pharmaceuticals, Inc. Reports Fourth Quarter 2020 Financial Results and Provides Business Update

March 3, 2021

Ampio Pharmaceuticals to Present at the H.C. Wainwright Global Life Sciences Conference

March 3, 2021

Ampio Pharmaceuticals, Inc. to Report Annual 2020 Financial Results and Provide Corporate Business Update

February 24, 2021
member-logo-85

© 2021 Ampio Pharmaceuticals Inc.

373 Inverness Parkway, Suite 200
Englewood, CO 80112 USA

Privacy Policy

Main office: +1 720 437 6500
Fax: +1 720 437 6501

General email inquiries: info@ampiopharma.com

  • Home
  • About Us
  • Pipeline
  • Manufacturing
  • Investors
  • News
  • Contact Us